aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.900
+0.076 (9.17%)
At close: Mar 9, 2026, 4:00 PM EDT
0.877
-0.023 (-2.52%)
After-hours: Mar 9, 2026, 6:11 PM EDT
aTyr Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 88 | 77 | 304 | 83 | 64 | 208 | |
| Market Cap Growth | -75.67% | -74.75% | 268.02% | 29.97% | -69.40% | 425.30% | |
| Enterprise Value | 15 | -1 | 251 | -5 | -5 | 93 | |
| Last Close Price | 0.82 | 0.78 | 3.62 | 1.41 | 2.19 | 7.47 | |
| PS Ratio | 432.20 | 403.86 | 1293.07 | 233.91 | 6.12 | - | |
| PB Ratio | 1.20 | 1.14 | 4.35 | 0.91 | 0.89 | 1.90 | |
| P/TBV Ratio | 1.22 | 1.14 | 4.34 | 0.91 | 0.89 | 1.90 | |
| EV/Sales Ratio | 81.39 | - | 1069.23 | - | - | - | |
| Debt / Equity Ratio | 0.18 | 0.18 | 0.19 | 0.17 | 0.16 | 0.01 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.84 | -0.92 | -0.77 | -0.98 | |
| Net Debt / EBITDA Ratio | 0.87 | 0.87 | 0.88 | 1.53 | 1.18 | 3.18 | |
| Net Debt / FCF Ratio | 1.07 | 1.07 | 0.85 | 2.22 | 1.25 | 3.20 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | - | |
| Quick Ratio | 5.25 | 5.25 | 4.93 | 6.13 | 5.62 | 18.02 | |
| Current Ratio | 5.30 | 5.30 | 5.48 | 6.27 | 5.83 | 18.89 | |
| Return on Equity (ROE) | -108.11% | -108.11% | -79.88% | -62.31% | -50.27% | -48.04% | |
| Return on Assets (ROA) | -51.12% | -51.12% | -39.03% | -31.72% | -27.45% | -27.56% | |
| Return on Capital Employed (ROCE) | -99.70% | -99.70% | -83.00% | -52.70% | -56.60% | -31.10% | |
| Earnings Yield | -90.26% | -96.59% | -21.07% | -61.03% | -71.36% | -16.27% | |
| FCF Yield | -75.58% | -80.88% | -22.77% | -45.34% | -68.51% | -16.02% | |
| Buyback Yield / Dilution | -25.21% | -25.21% | -38.53% | -88.63% | -48.94% | -108.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.